Issued Patents All Time
Showing 1–13 of 13 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12290558 | SARS-CoV-2 vaccines comprising human adenovirus vectors encoding spike and nucleocapsid-ETSD immunogens | Patrick Soon-Shiong, Peter Sieling, Kayvan Niazi, Shahrooz Rabizadeh, Lise Geissert +4 more | 2025-05-06 |
| 12274748 | Adenoviral vector transduced apheresis product | Patrick Soon-Shiong, Philip T. Liu | 2025-04-15 |
| 11857620 | Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus | Patrick Soon-Shiong, Peter Sieling, Kayvan Niazi, Shahrooz Rabizadeh, Lise Geissert +4 more | 2024-01-02 |
| 11352642 | Methods and compositions for combination immunotherapy | Frank R. Jones, Yvette Latchman, Adrian Rice | 2022-06-07 |
| 11304998 | Combination immunotherapies comprising IL-15 superagonists | Frank R. Jones, Adrian Rice, Yvette Latchman, Joseph P. Balint | 2022-04-19 |
| 11149087 | Methods and compositions for combination immunotherapy | Frank R. Jones, Yvette Latchman, Adrian Rice | 2021-10-19 |
| 11116827 | Compositions and methods for tumor vaccination and immunotherapy involving HER antigens | Frank R. Jones, Joseph P. Balint | 2021-09-14 |
| 11104916 | Compositions and methods for alphavirus vaccination | Frank R. Jones, Joseph P. Balint, Adrian Rice, Yvette Latchman | 2021-08-31 |
| 11020467 | Combination immunotherapies comprising IL-15 superagonists | Frank R. Jones, Adrian Rice, Yvette Latchman, Joseph P. Balint | 2021-06-01 |
| 10835596 | Compositions and methods for flavivirus vaccination | Frank R. Jones, Joseph P. Balint, Adrian Rice, Yvette Latchman | 2020-11-17 |
| 10695417 | Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein | Frank R. Jones | 2020-06-30 |
| 10563224 | Replication defective adenovirus vector in vaccination | Frank R. Jones | 2020-02-18 |
| 9605276 | Replication defective adenovirus vector in vaccination | Frank R. Jones | 2017-03-28 |